8-105803451-A-G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_012082.4(ZFPM2):​c.3369A>G​(p.Leu1123Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0115 in 1,613,764 control chromosomes in the GnomAD database, including 1,766 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.061 ( 920 hom., cov: 32)
Exomes 𝑓: 0.0063 ( 846 hom. )

Consequence

ZFPM2
NM_012082.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.256

Publications

4 publications found
Variant links:
Genes affected
ZFPM2 (HGNC:16700): (zinc finger protein, FOG family member 2) The zinc finger protein encoded by this gene is a widely expressed member of the FOG family of transcription factors. The family members modulate the activity of GATA family proteins, which are important regulators of hematopoiesis and cardiogenesis in mammals. It has been demonstrated that the protein can both activate and down-regulate expression of GATA-target genes, suggesting different modulation in different promoter contexts. A related mRNA suggests an alternatively spliced product but this information is not yet fully supported by the sequence. [provided by RefSeq, Jul 2008]
ZFPM2-AS1 (HGNC:50698): (ZFPM2 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.67).
BP6
Variant 8-105803451-A-G is Benign according to our data. Variant chr8-105803451-A-G is described in ClinVar as Benign. ClinVar VariationId is 414006.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.256 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.207 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_012082.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ZFPM2
NM_012082.4
MANE Select
c.3369A>Gp.Leu1123Leu
synonymous
Exon 8 of 8NP_036214.2
ZFPM2
NM_001362836.2
c.3210A>Gp.Leu1070Leu
synonymous
Exon 7 of 7NP_001349765.1
ZFPM2
NM_001362837.2
c.2973A>Gp.Leu991Leu
synonymous
Exon 8 of 8NP_001349766.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ZFPM2
ENST00000407775.7
TSL:1 MANE Select
c.3369A>Gp.Leu1123Leu
synonymous
Exon 8 of 8ENSP00000384179.2
ZFPM2
ENST00000517361.1
TSL:2
c.2973A>Gp.Leu991Leu
synonymous
Exon 6 of 6ENSP00000428720.1
ZFPM2
ENST00000520492.5
TSL:2
c.2973A>Gp.Leu991Leu
synonymous
Exon 8 of 8ENSP00000430757.1

Frequencies

GnomAD3 genomes
AF:
0.0611
AC:
9294
AN:
152186
Hom.:
917
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.210
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0276
Gnomad ASJ
AF:
0.00202
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.000749
Gnomad OTH
AF:
0.0406
GnomAD2 exomes
AF:
0.0158
AC:
3919
AN:
248094
AF XY:
0.0119
show subpopulations
Gnomad AFR exome
AF:
0.217
Gnomad AMR exome
AF:
0.0124
Gnomad ASJ exome
AF:
0.000897
Gnomad EAS exome
AF:
0.0000558
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000651
Gnomad OTH exome
AF:
0.00748
GnomAD4 exome
AF:
0.00635
AC:
9276
AN:
1461460
Hom.:
846
Cov.:
32
AF XY:
0.00546
AC XY:
3967
AN XY:
726976
show subpopulations
African (AFR)
AF:
0.213
AC:
7129
AN:
33468
American (AMR)
AF:
0.0137
AC:
611
AN:
44690
Ashkenazi Jewish (ASJ)
AF:
0.000957
AC:
25
AN:
26126
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39672
South Asian (SAS)
AF:
0.000568
AC:
49
AN:
86224
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53382
Middle Eastern (MID)
AF:
0.0111
AC:
64
AN:
5768
European-Non Finnish (NFE)
AF:
0.000440
AC:
489
AN:
1111766
Other (OTH)
AF:
0.0150
AC:
908
AN:
60364
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
451
902
1352
1803
2254
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
210
420
630
840
1050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0612
AC:
9327
AN:
152304
Hom.:
920
Cov.:
32
AF XY:
0.0586
AC XY:
4364
AN XY:
74488
show subpopulations
African (AFR)
AF:
0.211
AC:
8750
AN:
41542
American (AMR)
AF:
0.0276
AC:
422
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00202
AC:
7
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00166
AC:
8
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10630
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.000750
AC:
51
AN:
68038
Other (OTH)
AF:
0.0402
AC:
85
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
391
782
1172
1563
1954
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
84
168
252
336
420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0525
Hom.:
565
Bravo
AF:
0.0694
Asia WGS
AF:
0.0120
AC:
44
AN:
3478
EpiCase
AF:
0.000654
EpiControl
AF:
0.000832

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Apr 10, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

46,XY sex reversal 9 Benign:1
Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.67
CADD
Benign
2.3
DANN
Benign
0.73
PhyloP100
-0.26
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs16873744; hg19: chr8-106815679; API